Bailey Jeffrey Allen
CIK 0001500210
Chief Executive OfficerDirector
Filings
9
Latest Nov 24, 2025
Issuers covered
3
Showing
9 of 9
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -19.1% | -19.1% | -19.1% | -19.1% |
| 90 days | 1 | 100% | +6.1% | +6.1% | +6.1% | +6.1% |
| 180 days | 1 | 100% | +4.4% | +4.4% | +4.4% | +4.4% |
| 365 days | 1 | 0% | -84.7% | -84.7% | -84.7% | -84.7% |
Issuers
Companies where Bailey Jeffrey Allen has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 5 | Nov 24, 2025 |
| BDSI | Biodelivery Sciences International Inc | 3 | Mar 22, 2022 |
| ALRN | Aileron Therapeutics Inc | 1 | Jun 17, 2022 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|